Canada’s ARTMS registers cyclotron production of gallium-68

27 October 2021

ARTMS, a Canadian producer of medical isotopes has registered the cyclotron production of gallium-68 with the government of Canada, filing a Type 1 Master File with the Health Products & Food Branch of Health Canada.

The Ga-68 radioisotope is used in nuclear medicine diagnostic procedures utilizing positron emission tomography (PET) imaging. ARTMS said the filing will help alleviate the current Ga-68 supply constraints and provide innovators the ability to advance new radiopharmaceutical drugs into development.

ARTMS has also entered into a three-party cooperation for the development and clinical use of innovative radiopharmaceuticals in Canada. The partners joining ARTMS are POINT Biopharma and the Canadian Molecular Imaging Probe Consortium, or CanProbe, a joint venture between the Centre for Probe Development and Commercialisation and the University Health Network.

“The Ga-68 regulatory filing in Canada is the next step in ARTMS’ goal to prevent the significant supply issues of this important medical isotope,” said ARTMS CEO Charles S Conroy. “The current supply chain of germanium/gallium generators is inefficient, high cost, and at risk for interruption at any time.”

Joe McCann, CEO of POINT Biopharma, added, “Increasing the availability and scale of Ga-68 supply through cyclotron production will be important in further accelerating the development and commercialisation of next-generation radiopharmaceutical therapies. We believe ARTMS’ solid target approach to Ga-68 production will play a key role in increasing the availability of this important isotope.”

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.